https://phrma.org/blogs/rss PhRMA Blog RSS Feed for Sitecore Send Repeatable Campaigns en-us 13725 https://phrma.org/blog/mfn-price-controls-threaten-american-jobs-and-the-u-s-economy Matthew Norawong, May 28, 2026 Policymakers are weighing a misguided price-control policy that would put U.S. jobs, manufacturing and economic strength at risk, all while doing little to lower costs for patients. Thu, 28 May 2026 17:14:26 GMT 13724 https://phrma.org/blog/america-s-cancer-research-progress-is-real-and-worth-protecting Drew Voytal, May 28, 2026 National Cancer Research Month is a reminder that smart policies and sustained investment have made America the global leader in cancer research. Maintaining this important leadership is not guaranteed. Thu, 28 May 2026 15:46:07 GMT 13723 https://phrma.org/blog/340b-is-growing-but-it-is-unclear-if-illinois-patients-benefit Will May, May 27, 2026 A program distorted: Congress created the federal 340B program in 1992 to help vulnerable and uninsured patients access medicines. What once served fewer than 100 safety-net hospitals is now the second-largest federal prescription drug program—topping $81 billion and serving as a cash cow for large hospital systems, for-profit pharmacies, pharmacy benefit managers (PBMs) and other middlemen. Wed, 27 May 2026 17:20:04 GMT 13722 https://phrma.org/blog/ahead-of-asco-cancer-innovation-is-promising-but-policy-choices-matter Mike Ybarra, May 26, 2026 I’m looking forward to being back in Chicago for the American Society of Clinical Oncology (ASCO) annual meeting as we stand on the cusp of a new era in cancer care. Between the data presented at the American Association for Cancer Research last month and what we expect to see at ASCO, the next generation of treatments is coming into focus. Tue, 26 May 2026 17:41:26 GMT 13714 https://phrma.org/blog/new-research-reinforces-the-importance-of-hepatitis-b-vaccination-at-birth Carolyn Ha, May 21, 2026 May is Hepatitis Awareness Month, and new research underscores a key point: Giving the hepatitis B vaccine at birth is critical to preventing serious, often lifelong disease. Thu, 21 May 2026 17:30:10 GMT 13711 https://phrma.org/blog/state-price-setting-boards-create-more-questions-than-answers Reid Porter, May 20, 2026 The big picture: States are rolling out complex drug price-setting efforts—but there is no evidence yet that patients are or will save money at the pharmacy counter. Wed, 20 May 2026 04:00:00 GMT 13710 https://phrma.org/blog/fox-business-spotlights-hospitals-abuse-of-the-340b-program Chanse Jones, May 15, 2026 New Fox Business reporting is putting a national spotlight on growing concerns around the 340B program, including questions about transparency, accountability and whether patients are truly benefiting from the discounts. Fri, 15 May 2026 16:45:29 GMT 13652 https://phrma.org/blog/new-analysis-highlights-access-to-new-medicines-in-the-united-states-and-abroad Hannah Loiacono, May 13, 2026 A new PhRMA analysis shows the vast divide between the number of new medicines available to patients in the United States – and how quickly – versus 19 other high-income countries.  Wed, 13 May 2026 04:00:00 GMT 13597 https://phrma.org/blog/the-wall-street-journal-raises-new-alarms-about-340b Molly Jenkins, May 11, 2026 The Wall Street Journal Editorial Board is once again raising concerns about the federal 340B program – this time questioning whether the program is benefiting patients at all.   Mon, 11 May 2026 13:53:57 GMT 13594 https://phrma.org/blog/mfn-won-t-lower-costs-when-insurers-call-the-shots Brianna Allen, May 8, 2026 MFN ties U.S. drug prices to other countries, but it won’t guarantee lower costs for patients. That’s because insurers still control the decisions that matter to Americans — which medicines are covered, what hurdles patients can face like prior authorization, and how much they pay out of pocket at the pharmacy. Fri, 08 May 2026 15:27:00 GMT 13589 https://phrma.org/blog/hospitals-in-the-hot-seat-congress-sharpens-focus-on-340b-consolidation-and-rising-costs Eliza Maciag, May 7, 2026 The recent House Ways & Means hearing on rising health care costs marked a notable escalation in congressional scrutiny of hospital pricing, consolidation and 340B-related abuses, particularly from Chairman Jason Smith. Thu, 07 May 2026 18:12:35 GMT 13587 https://phrma.org/blog/advancing-mental-health-in-may-and-beyond Kristen Booze, May 7, 2026 The reality: Nearly one in four adults in the U.S. experienced a mental health condition in the past year, and many did not get the care they needed. That gap between need and treatment is what makes Mental Health Awareness Month so important each May. It’s a reminder of something both simple and urgent: Mental health is health. And when patients are sick, they may need a medicine as part of their treatment plan. Thu, 07 May 2026 17:09:21 GMT 13579 https://phrma.org/blog/new-goldmine-ad-reveals-hospitals-hide-how-they-profit-from-340b-markups Elise Shutzer, May 6, 2026 PhRMA launched a new ad campaign today to highlight how large, non-profit hospitals are exploiting the 340B program for profits that can be used in egregious ways with no patient benefit.   Wed, 06 May 2026 04:00:00 GMT 13578 https://phrma.org/blog/ustr-s-2026-special-301-report-stands-up-for-american-innovation Ernest Kawka, May 4, 2026 Last week, the Office of the United States Trade Representative (USTR) released its 2026 Special 301 Report. The annual report highlights foreign government policies that unfairly limit American innovation.  Mon, 04 May 2026 17:03:39 GMT